• SENSEX
    NIFTY 50
Healthcare

Cipla gets 8 observations from USFDA for Kurkumbh plant

Updated : March 31, 2019 10:33 PM IST

The company has also received 10 observations pertaining to a product-specific pre-approval (PAI) from the same plant, Cipla said in a BSE filing.
"These observations are both product specific and GMP observations related to the manufacturing and quality processes," the company said.
Cipla gets 8 observations from USFDA for Kurkumbh plant

You May Also Like

Live TV

recommended for you

Advertisement